Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "aimed at new equity fund investors"
1
Jul 22, 2008 06:11AM

Mark...

IBIS will not try to sell and no new equity fund investors will purchase stock unless at least 1 or 2 patents are re-certified or super strong personal assurances that they will be.

So we hired someone who will do nothing... I do not think so!!!



... We currently have 4 funds/institutional investors... one is a small fund and we are thier largest holding.... & yes ther PTO rulings are critical.... But when investing you often play the odds and you want to buy when others do not want it that is how you make a Profit....

We have 46% holocom... we are moving up over 40 on Talis.... we have just entered into an agreement with Nupower(to grow our patten portfolio)... we also are in the process of working a deal with a streaming content... our cash to stock price is under 4... our trailing PE is under 5... we will post postive earnings this 1/4...

how much risk is here... you had the odds of the PTO ruling in our favor..... & why not invest...(before you answer with your not being able to go after tier 2.... we still have teir 1's.... )



Mark are youy trying to buy low... Why are you always bashing....???



6
Jul 22, 2008 07:53AM
4
Jul 22, 2008 07:56AM
Share
New Message
Please login to post a reply